These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 38118010)

  • 1. Utility and Evaluation of Applied Project Management Processes Within a Large Multicountry Health Systems Development Project Conducted During the Coronavirus Disease 2019 (COVID-19) Pandemic.
    Kwon SY; Gautam S; Poudel K; Banneheke H; Ferreira D; Gautam M; Hau'ofa M; Mahmood N; Phommalad B; Sujan MJ; Yangzom P; Joh HS; Shaw A; Dolabella B; Seo HJ; Kim JH; Gallagher P; MacWright WR; Poudyal N; Marks F; Holm M
    Clin Infect Dis; 2023 Dec; 77(Suppl 7):S543-S548. PubMed ID: 38118010
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CAPTURA Regional Workshop Proceedings (28-30 June 2022, Virtual).
    Joh HS; Dolabella B; Early E; Stelling J; Ak G; Upadhyaya MK; Rahman A; Chuki P; MacWright WR; Ondoa P; Sarkar S; Moore C; Holm M; Leslie T; Zellweger RM; Paing G; Kwon SY; Marks F; Poudyal N
    Clin Infect Dis; 2023 Dec; 77(Suppl 7):S536-S542. PubMed ID: 38118006
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Capturing Data on Antimicrobial Resistance Patterns and Trends in Use in Regions of Asia (CAPTURA).
    Holm M; MacWright WR; Poudyal N; Shaw AG; Joh HS; Gallagher PF; Kim JH; Shaikh AT; Seo HJ; Kwon SY; Prifti K; Dolabella B; Taylor BEW; Yeats C; Aanensen DM; Stelling J; Marks F
    Clin Infect Dis; 2023 Dec; 77(Suppl 7):S500-S506. PubMed ID: 38118015
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Methodological Approach to Identify and Expand the Volume of Antimicrobial Resistance (AMR) Data in the Human Health Sector in Low- and Middle-Income Countries in Asia: Implications for Local and Regional AMR Surveillance Systems Strengthening.
    Joh HS; Yeats C; Shaw A; Poudyal N; Gallagher P; Kim JH; Shaikh A; Seo HJ; Chi KK; Prifti K; Cho A; Sujan MJ; Eraly E; Pham KD; Shrestha S; Aboushady AT; Pak G; Jang G; Park EL; Seo HW; Abudahab K; Taylor BEW; Clark A; Dolabella B; Yoon H; Han J; Kwon SY; Marks F; Stelling J; Aanensen DM; MacWright WR; Holm M
    Clin Infect Dis; 2023 Dec; 77(Suppl 7):S507-S518. PubMed ID: 38118007
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effective Stakeholder Engagement for Collation, Analysis and Expansion of Antimicrobial Resistance (AMR) Data: A CAPTURA Experience.
    Poudyal N; Holm M; Joh HS; Gautam S; Sujan MJ; Kwon SY; Sahikh A; Shaw A; Gallagher P; Prifti K; Cho A; Chi KK; Aboushady AT; MacWright WR; Stelling J; Marks F
    Clin Infect Dis; 2023 Dec; 77(Suppl 7):S519-S527. PubMed ID: 38118005
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Reality of Antimicrobial Resistance and Antibiotic Usage Data in Asia: The CAPTURA Experience.
    Leslie T; Parry C; Ondoa P; Walsh T; Moore C; Poudyal N; Marks F; Gordon NC
    Clin Infect Dis; 2023 Dec; 77(Suppl 7):S497-S499. PubMed ID: 38118008
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluating Quality Management and Diagnostics Microbiology Performance Within an International External Quality Assessment (EQA) Program Serving National One Health Sector Reference Laboratories Across Asia: Experience Amid the Coronavirus Disease 2019 (COVID-19) Pandemic.
    Abegaz FA; Dos Santos PT; Mogeni OD; Guarnacci T; Poudyal N; Hong J; Kwon SY; Braae R; Prathan R; Tongkum TL; Kamjumpho W; Chuanchuen R; Marks F; Hendriksen RS; Holm M
    Clin Infect Dis; 2023 Dec; 77(Suppl 7):S588-S596. PubMed ID: 38118017
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Key Recommendations for Antimicrobial Resistance Surveillance: Takeaways From the CAPTURA Project.
    Aboushady AT; Sujan MJ; Pham K; Clark A; Marks F; Holm M; Joh HS; Poudyal N; Stelling J
    Clin Infect Dis; 2023 Dec; 77(Suppl 7):S581-S587. PubMed ID: 38118016
    [TBL] [Abstract][Full Text] [Related]  

  • 9. How can lessons from the COVID-19 pandemic enhance antimicrobial resistance surveillance and stewardship?
    Walia K; Mendelson M; Kang G; Venkatasubramanian R; Sinha R; Vijay S; Veeraraghavan B; Basnyat B; Rodrigues C; Bansal N; Ray P; Mathur P; Gopalakrishnan R; Ohri VC
    Lancet Infect Dis; 2023 Aug; 23(8):e301-e309. PubMed ID: 37290476
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A rapid mixed-methods evaluation of remote home monitoring models during the COVID-19 pandemic in England.
    Fulop NJ; Walton H; Crellin N; Georghiou T; Herlitz L; Litchfield I; Massou E; Sherlaw-Johnson C; Sidhu M; Tomini SM; Vindrola-Padros C; Ellins J; Morris S; Ng PL
    Health Soc Care Deliv Res; 2023 Jul; 11(13):1-151. PubMed ID: 37800997
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interventional research to tackle antimicrobial resistance in Low Middle Income Countries in the era of the COVID-19 pandemic: lessons in resilience from an international consortium.
    Birgand G; Charani E; Ahmad R; Bonaconsa C; Mbamalu O; Nampoothiri V; Surendran S; Weiser TG; Holmes A; Mendelson M; Singh S;
    Int J Infect Dis; 2022 Apr; 117():174-178. PubMed ID: 35150912
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recording and Reporting of Antimicrobial Resistance (AMR) Priority Variables and Its Implication on Expanding Surveillance Sites in Nepal: A CAPTURA Experience.
    Maharjan S; Gallagher P; Gautam M; Joh HS; Sujan MJ; Aboushady AT; Kwon SY; Gautam S; Upadhyaya MK; Jha R; Acharya J; MacWright WR; Marks F; Stelling J; Poudyal N
    Clin Infect Dis; 2023 Dec; 77(Suppl 7):S560-S568. PubMed ID: 38118014
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of a cross-sectoral antimicrobial resistance capability assessment framework.
    Ferdinand AS; McEwan C; Lin C; Betham K; Kandan K; Tamolsaian G; Pugeva B; McKenzie J; Browning G; Gilkerson J; Coppo M; James R; Peel T; Levy S; Townell N; Jenney A; Stewardson A; Cameron D; Macintyre A; Buising K; Howden BP
    BMJ Glob Health; 2024 Jan; 9(1):. PubMed ID: 38232993
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of the COVID-19 pandemic on the surveillance, prevention and control of antimicrobial resistance: a global survey.
    Tomczyk S; Taylor A; Brown A; de Kraker MEA; El-Saed A; Alshamrani M; Hendriksen RS; Jacob M; Löfmark S; Perovic O; Shetty N; Sievert D; Smith R; Stelling J; Thakur S; Vietor AC; Eckmanns T;
    J Antimicrob Chemother; 2021 Oct; 76(11):3045-3058. PubMed ID: 34473285
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antimicrobial Resistance Surveillance Methods in Bangladesh: Present and Way Forward.
    Sujan MJ; Habib ZH; Rahman A; Rizvi SMS; Barua HT; Aboushady AT; Hasnat MA; Rasul SBG; Joh HS; Prifti K; Chi KK; Kwon SY; Clark A; Gautam S; Holm M; Marks F; Stelling J; Shaw A; Poudyal N
    Clin Infect Dis; 2023 Dec; 77(Suppl 7):S549-S559. PubMed ID: 38118018
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antimicrobial resistance in low- and middle-income countries: current status and future directions.
    Sulis G; Sayood S; Gandra S
    Expert Rev Anti Infect Ther; 2022 Feb; 20(2):147-160. PubMed ID: 34225545
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multi-sectoral collaborations in selected countries of the Eastern Mediterranean region: assessment, enablers and missed opportunities from the COVID-19 pandemic response.
    El-Jardali F; Fadlallah R; Daher N
    Health Res Policy Syst; 2024 Jan; 22(1):14. PubMed ID: 38267995
    [TBL] [Abstract][Full Text] [Related]  

  • 18. COVID-19 surveillance in Democratic Republic of Congo, Nigeria, Senegal and Uganda: strengths, weaknesses and key Lessons.
    Fawole OI; Bello S; Adebowale AS; Bamgboye EA; Salawu MM; Afolabi RF; Dairo MD; Namale A; Kiwanuka S; Monje F; Namuhani N; Kabwama S; Kizito S; Ndejjo R; Seck I; Diallo I; Makhtar M; Leye M; Ndiaye Y; Fall M; Bassoum O; Mapatano MA; Bosonkie M; Egbende L; Lazenby S; Wang W; Liu A; Bartlein R; Sambisa W; Wanyenze R
    BMC Public Health; 2023 May; 23(1):835. PubMed ID: 37158897
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Coronavirus Disease 2019 and Antimicrobial Resistance: Parallel and Interacting Health Emergencies.
    Nieuwlaat R; Mbuagbaw L; Mertz D; Burrows LL; Bowdish DME; Moja L; Wright GD; Schünemann HJ
    Clin Infect Dis; 2021 May; 72(9):1657-1659. PubMed ID: 32544232
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SARS-CoV-2 Wave Two Surveillance in East Asia and the Pacific: Longitudinal Trend Analysis.
    Post LA; Lin JS; Moss CB; Murphy RL; Ison MG; Achenbach CJ; Resnick D; Singh LN; White J; Boctor MJ; Welch SB; Oehmke JF
    J Med Internet Res; 2021 Feb; 23(2):e25454. PubMed ID: 33464207
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.